Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea

Purpose Triple-negative breast cancer (TNBC) accounts for 10–20% of all diagnosed BCs and it is enriched in BRCA1 mutation. Guidelines for Western countries suggest that BRCA 1 / 2 genetic testing should be done for patients with TNBC diagnosed less than 60 years, but there is lack of evidence suppo...

Full description

Saved in:
Bibliographic Details
Published in:Breast cancer research and treatment Vol. 173; no. 2; pp. 385 - 395
Main Authors: Ryu, Jai Min, Choi, Hee Jun, Kim, Isaac, Nam, Seok Jin, Kim, Seok Won, Yu, Jonghan, Lee, Se Kyung, Choi, Doo Ho, Park, Yeon Hee, Kim, Jong-Won, Seo, Jeong-sun, Park, Jung-Hoon, Lee, Jeong Eon, Kim, Sung-Won
Format: Journal Article
Language:English
Published: New York Springer US 01.01.2019
Springer
Springer Nature B.V
Subjects:
ISSN:0167-6806, 1573-7217, 1573-7217
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first